Artificial intelligence (AI) is transforming cancer profiling and pathway technologies by shifting workflows from manual interpretation to data-driven decision support. AI analyzes complex genomic, transcriptomic, proteomic, and pathology data to support treatment selection, patient classification, and biomarker discovery. It also improves interpretability, scalability, and standardization in research and clinical workflows, supporting wider adoption of precision oncology.
Report Includes
- Impact analysis of artificial intelligence (AI) on the global cancer profiling and pathways technologies market
- Case studies for successful integration of AI and machine learning in biomarker discovery, molecular profiling, pathway analysis and data-driven oncology research
- Highlights of AI adoption trends across major geographical regions, as well as disruptions caused by AI across key oncology, diagnostics, pharmaceutical and biotechnology industry verticals
- AI role in precision oncology, translational research, product development and clinical decision-making
- Review of AI impact on the various stages of the global cancer profiling and pathways technologies value chain and supply chain analysis
- Competitive landscape featuring key strategic initiatives, market spendings and an investment outlook
Table of Contents
Chapter 1 Key Use Cases for AI Implementation- Key Use Cases
- Use Case 1: AI-Enabled Variant Interpretation and Pathway Mapping
- Use Case 2: AI-Assisted Digital Pathology and Biomarker Quantification
- Use Case 3: AI-Driven Therapy Matching and Clinical Trial Identification
- Overview
- Adoption Trends by Region
- Adoption Trends in North America
- Adoption Trends in Europe
- Adoption Trends in Asia Pacific
- Adoption Trends in the Rest of the World
- Overview
- Impact of AI on Key Industry Verticals
- Clinical and Reference Laboratories
- Hospitals and Cancer Centers
- Biopharmaceutical and Biotechnology Companies
- Contract Research Organizations and Trial Networks
- Technology and Platform Vendors
- Health Systems and Payers
- Impact of AI on the Supply Chain
- Plan and Source (Demand Forecasting, Capacity Alignment, and Input Readiness)
- Analyze and Interpret (AI-Augmented Molecular and Pathway Analysis)
- Quality, Validation, and Compliance (Structured Evidence Generation and Governance at Scale
- Deliver and Improve (Report Delivery, Performance Feedback, and Continuous Optimization)
- Overview
- Key Spending in AI in the Cancer Profiling and Pathways Technologies Industry
- Abbreviations Used in the Report
Table 1: Recent Development in AI in Cancer Profiling and Pathways Technologies Industry, 2024-2025
Table 2: Abbreviations Used in This Report
List of Figures
Figure 1: Impact of AI on the Cancer Profiling and Pathways Technologies Supply Chain
